Abstract
High dietary fat intake is associated with metabolic dysregulation, but little is known regarding the effects of a high fat diet (HFD) on photoreceptor cell functioning. We explored the intersection of an HFD and the visual cycle adducts that form in photoreceptor cells by nonenzymatic reactions. In black C57BL/6J mice and albino C57BL/6Jc2j mice raised on an HFD until age 3, 6, or 12 months, chromatographically quantified bisretinoids were increased relative to mice on a standard diet. In vivo measurement of fundus autofluorescence, the source of which is bisretinoid, also revealed a significant increase in the HFD mice. Additionally, mice provided with a diet high in fat presented with elevated retinol-binding protein 4, the protein responsible for transporting retinol in plasma. Vitamin A was elevated in plasma although not in ocular tissue. Bisretinoids form in photoreceptor cell outer segments by random reactions of retinaldehyde with phosphatidylethanolamine. We found that the latter phospholipid was significantly increased in mice fed an HFD versus mice on a control diet. In leptin-deficient ob/ob mice, a genetic model of obesity, plasma levels of retinol-binding protein 4 were higher but bisretinoids in retina were not elevated. Photoreceptor cell viability measured as outer nuclear layer thickness was reduced in the ob/ob mice relative to WT. The accelerated formation of bisretinoid we observed in diet-induced obese mice is related to the high fat intake and to increased delivery of vitamin A to the visual cycle.
Keywords: diet-induced obesity, vitamin A, retina, phosphatidylethanolamine, retinol-binding protein 4
Throughout the lifetime of an individual, vitamin A aldehyde adducts (bisretinoids) form randomly and nonenzymatically by the reaction of retinaldehyde with photoreceptor outer segment lipid—specifically, phosphatidylethanolamine (PE) (1). Bisretinoids are transferred to retinal pigment epithelial (RPE) cells within phagocytosed outer segment disks and accumulate as lipofuscin (2, 3, 4, 5, 6). These bisretinoid fluorophores can be measured chromatographically (7, 8). In addition, since they are the source of short wavelength fundus autofluorescence (SW-AF; 488 nm, blue excitation) that is detected spectrophotometrically (9) and imaged noninvasively by confocal fluorescence scanning laser ophthalmoscopy (10), methods for quantifying fundus autofluorescence (quantitative fundus autofluorescence; qAF) in human subjects/patients and mice are also in use (11, 12, 13, 14, 15, 16).
Bisretinoids exhibit properties having adverse consequences for cells. For instance, these compounds are photosensitizers having a propensity to generate reactive forms of oxygen including superoxide anion and singlet oxygen (17, 18). These reactive species subsequently add to carbon-carbon double bonds within the side-arms of the bisretinoid molecule; the latter eventually photodegrade, releasing damaging aldehyde- and dicarbonyl-bearing molecular fragments. Although all healthy eyes accumulate bisretinoids with age (14, 15, 19, 20, 21, 22), there are some variables that are known to influence the quantities accrued. For instance, levels of bisretinoid at any given time reflect the balance between formation in photoreceptor cells versus photodegradative loss (15, 23). It is also known that the rate of bisretinoid formation can be modulated by visual cycle kinetics. Thus, limiting delivery of vitamin A to RPE (24, 25) or reducing the activity of the isomerase RPE65 by a murine gene variant (26), null mutation (27, 28), or by small molecules that target RPE65 (29, 30, 31) also reduces or abrogates bisretinoid formation. Similar effects are observed in humans carrying deficiencies in other proteins of the visual cycle including lecithin retinol acyltransferase, cellular retinaldehyde-binding protein, and 11-cis retinol dehydrogenase (32, 33). Conversely, disease-causing mutations in ATP-binding cassette transporter A4 and retinol dehydrogenases cause mishandling of vitamin A aldehyde and accelerated formation of bisretinoid (34, 35, 36, 37).
Noninvasive measurement of bisretinoid by qAF has also revealed higher levels in individuals self reporting as female and White and lower in Asians and Blacks (14). Another variable is smoking; qAF is higher in subjects that identify as smokers (14). Nevertheless, the considerable difference in fundus autofluorescence intensities (∼3-fold range) (14) among individuals of similar age are not fully accounted for. Since supplementation with vitamin A in mice is known to increase the accumulation of bisretinoid lipofuscin (38) and a high fat diet (HFD) can increase serum vitamin A (39, 40), we have undertaken to determine whether dysregulation of vitamin A aldehyde in association with an HFD can lead to increased formation of the vitamin A aldehyde adducts (retinaldehyde-adducts, bisretinoids) that constitute the lipofuscin of retina and have adverse consequences for RPE and photoreceptor cells. We have studied two mouse models of obesity, obesity due to an HFD and obesity due to deficiency in leptin (Lepob/ob; ob/ob), a hormone that is produced in adipose tissue and is involved in regulating energy expenditure and food intake (41).
Results
Bisretinoids in HFD-fed mice
To undertake studies of a relationship between obesity and bisretinoid levels, mice were raised on an HFD (60% kcal from fat) and comparison was made to mice raised on a standard control (10% kcal from fat) diet. Accordingly, we studied black C57BL/6J mice receiving an HFD or control diet beginning at 6 weeks of age with tissue collection at 6 months of age. The body weight of the HFD-fed mice was 46.4 g (±2.9, SD), a 37% increase over the mice on a standard diet (33.9 ± 2.7 g (mean ± SD)) (p < 0.001, unpaired two-tailed t test). Peaks in the HPLC and ultra-performance liquid chromatography (UPLC) chromatograms were identified as A2E, isoA2E, A2-DHP-PE, and A2GPE on the basis of UV-visible absorbance spectra and retention times (Rt) that were consistent with authentic synthesized standards (7, 20, 42, 43). Accordingly, by reverse phase HPLC, we quantified A2E (the sum of all-trans and cis-isomers) and A2-DHP-PE by HPLC and A2-GPE by UPLC (Fig. 1A). In the eyes of HFD-fed mice, there was a 1.4-fold difference in A2-GPE (p < 0.01) and a 5.5-fold change in A2-DHP-PE (p < 0.001; two-way ANOVA, Sidak’s multiple comparisons test) (Fig. 1B). An independent t test conducted to compare total measured bisretinoid in the HFD-fed mice (10.2 ± 1.4) to total measured bisretinoid in the control mice (6.1 ± 0.9) revealed a statistically significant difference (p < 0.01) with a large effect size (d = 5.1).
Given that bisretinoids can undergo loss by photodegradation, we also compared albino C57BL/6Jc2j mice that were fed an HFD from age 6 weeks to 12 months of age with C57BL/6Jc2j mice on a standard diet. The final weight of the HFD-fed mice (55.9 ± 5 gm) was 30% greater than the weight of the control mice (43.2 ± 5.9 gm; mean ± SD) (p < 0.01, unpaired two-tailed t test) (Fig. 1C). Blood glucose was also elevated in these mice (HFD: 211 ± 31; control: 181 ± 15.9, mean ± SD, mg/dl) (p < 0.01, unpaired two-tailed t test) (Fig. 1D). The levels of A2E in obese C57BL/6Jc2j HFD-fed mice were more than 2-fold greater than in the mice fed the standard diet (HFD: 22.5 ± 4.8; control: 10.6 ± 4.1, mean ± SD; p < 0.01, two-way ANOVA and Sidak’s multiple comparisons test), and similar increases in the bisretinoid A2-DHP-PE (2-fold) were also measured (A2-GPE, HFD: 10.1 ± 1.6; control: 4.7 ± 1.2, mean ± SD; p > 0.05, Sidak’s multiple comparisons test) (A2-DHP-PE p < 0.05, Sidak’s multiple comparisons test) (Fig. 1E).
An independent t test reported a statistically significant difference (p < 0.01) between total measured bisretinoid in the HFD-fed mice (32.7 ± 6.3) versus control mice (15.3 ± 5.3). In this analysis, the effect size was large (d = 4.3). It was also clear that the increase in bisretinoid formation in the HFD-fed albino mice was not off-set by photodegradation in mice exposed to higher levels of intraocular light.
Fundus imaging to measure SW-AF noninvasively (qAF) (15), the source of which is bisretinoid, revealed that qAF was 35% higher in the HFD-fed mice (1.1 ± 0.12, mean ± SD) than in the control mice (0.8 ± 1.0, mean ± SD; p < 0.05, unpaired t test) (Fig. 1F). The effect size (d = 2.5) met the benchmark of a large effect. This increase in bisretinoid in the C57BL/6Jc2j mice was not associated with a change in photoreceptor cell viability. Specifically, no difference in outer nuclear layer (ONL) area was observed when mice receiving the HFD were compared to those receiving the standard diet at age 13 months (p > 0.05, unpaired two-tailed t test) (Fig. 1G).
In a study of C57BL/6J mice as old as 32 months, it has been demonstrated that scotopic and photopic a- and b-wave ERG amplitudes are reduced and ONL thicknesses are diminished (44). We were similarly interested how aging may affect the impact of an HFD. Thus, we also studied bisretinoids in extremely old (36 months) C57BL/6J mice. As shown in Figure 1H, in these 3-year-old mice reared on an HFD, atRALdi-PE was increased 2.4-fold in the diet-induced obese mice compared to mice on the standard (10% fat) diet (p < 0.01, two-way ANOVA, Sidak’s multiple comparisons test). Similarly, A2E (the sum of all A2E isomers) was 1.9-fold higher in the diet-induced obese mice relative to mice on the standard (10% fat) diet, while the increase in A2-DHP-PE was 2.5 greater (not statistically significant, p > 0.05). The mice receiving the HFD for 3 years weighed 56.6 ± 12.2 g as compared to a weight of 34.3 ± 2.3 g (mean ± SD) exhibited by mice on the control diet, but the weights of the HFD-fed 3-year-old and 1-year-old mice were similar. An expected age-related increase in bisretinoid was observed: total bisretinoid in the HFD-fed and control 3-year-old mice (the sum of A2E and A2-DHP-PE; 15.5 and 7.4 pmoles, respectively; Fig. 1H) was greater than in the 6-month-old black HFD-mice (the sum of A2E and A2-DHP-PE; 10.2 and 6.1 pmoles/eye, respectively; Fig. 1B).
Plasma Rbp4
For transport to cells, including the RPE, vitamin A forms a holo-enzyme complex with retinol-binding protein 4 (RBP4) and transthyretin (TTR) (45, 46). Thus, we measured Rbp4 levels in mouse plasma by ELISA using antibody to mouse Rbp4 protein. Rbp4 levels in the plasma of the HFD-fed C57BL/6Jc2j mice were elevated relative to control mice on a standard diet (p < 0.001, two-way ANOVA, Sidak’s multiple comparison test) at 12 months of age (Fig. 2A). We also measured Rbp4 levels in black C57BL/6J mice receiving an HFD or control diet beginning at 6 weeks of age with plasma collection at 6 months of age. In the plasma of HFD-fed mice, there was a 1.3-fold increase in Rbp4 (p < 0.05; 1-way ANOVA, Sidak’s multiple comparisons test) (Fig. 2A). The effect size (d = 4.5) was large.
Retinoid levels in HFD-fed mice
To determine whether an HFD diet increases delivery of vitamin A to retina as a prelude to elevated bisretinoid lipofuscin formation, we also measured retinoids in plasma. In C57BL/6J mice receiving the HFD (age 14 weeks), there was a 2.2-fold increase (p < 0.0001; two-way ANOVA and Sidak’s multiple comparisons test) in all-trans-retinol (vitamin A) in plasma collected at euthanasia (Fig. 2B). The analysis also revealed a large effect size (d = 8.4). All-trans-retinyl ester was also detected in the plasma, but statistically significant differences were not observed (47).
In eyes harvested from light-adapted C57BL/6J mice fed an HFD versus standard diet (age 16 weeks), there were no statistically significant differences in the levels of retinoids including all-trans-retinol, all-trans-retinyl ester, all-trans-retinal, or 11-cis-retinal (Fig. 2C). Similarly, there were no statistically significant differences in the retinoid content of eyes acquired from HFD-fed albino C57BL/6Jc2j mice (light adapted; age 12 months) versus the control diet. In keeping with higher intraocular light levels in albino eyes, 11-cis retinal was less abundant in the albino (Fig. 2D). There was also no difference in total retinoid levels in dark-adapted black C57BL/6J mice fed an HFD (age 3.5 months) (Fig. 2C).
PE assay
PE is a neutral phospholipid consisting of a phosphatidyl group with an ester linked to ethanolamine. Since bisretinoids form in photoreceptor cell outer segments by random reactions of retinaldehyde with PE, we also assayed PE content. Since approximately 80% of the cells in mouse retina are photoreceptors (48, 49, 50) and in photoreceptor outer segments, PE constitutes 37.6 mol% of the phospholipids (51) we employed isolated neural retina for these measurements. We found that in black C57BL/6J mice fed an HFD, PE was 37% higher than in mice on the control diet (p < 0. 001; two-way ANOVA and Sidak’s multiple comparisons test) (Fig. 3A). In this analysis, the effect size was large (d = 3.6).
Findings in ob/ob mice
Leptin-deficient ob/ob mice are a genetic model of obesity. Ob/ob mice become morbidly obese on a standard diet due to excessive food intake; the development of obesity is more rapid and severe than with HFD (52). Thus, we set out to determine whether this genetic model of obesity (ob/ob) on a C57BL/6J background is associated with elevated ocular retinoids and whether formation of vitamin A aldehyde adducts (bisretinoid lipofuscin) is increased.
Within our cohort of black ob/ob mice, we observed the mice to be 42.0 ± 3.4 g at 2 months and as much as 71.1 ± 6.2 g at 8 months (mean ± SD). Plasma levels of Rbp4 protein were also higher in the ob/ob mice (Fig. 4A), as has been previously reported (52, 53, 54). In the ob/ob mice, Rbp4 was 2.9 higher than in WT C57BL/6J mice with a large effect size (d = 8.7) (p < 0.0001, unpaired two-tailed t test) (Fig. 4A).
In eyes collected from light-adapted ob/ob versus WT mice (age 2 months), there were no statistically significant differences in the levels of retinoids including all-trans-retinol, all-trans-retinyl ester, all-trans-retinal, or 11-cis-retinal (Fig. 4B). We measured retinal bisretinoids by HPLC. In a comparison of ob/ob and WT mice, no differences were observed in A2E (the sum of all isomers) nor in A2-DHP-PE. At 6 and 8 months of age, all-trans-retinal dimer-PE levels were sufficient for quantitation, but no differences were observed between ob/ob and C57BL/6J mice. Conversely, we observed consistently lower levels of A2-GPE in the ob/ob mice. The difference at 2 months of age was 13% (p < 0.05, two way-ANOVA, Sidak’s multiple comparison test), while at 4 and 6 months, A2-GPE was 34% and 37% lower, respectively (p < 0.01) (Fig. 4C). The difference at age 8 months was not statistically significant (p > 0.05). Since bisretinoids are the source of SW-AF that is imaged in vivo, we used the qAF approach to quantify SW-AF (qAF) in black-coated ob/ob mice (15, 55). As expected, we observed an age-related increase in qAF in the ob/ob mice (Fig. 4D), but qAF intensities were not different in the ob/ob mice as compared to C57BL/6J mice at 2 and 4 months of age nor was there a difference in near-infrared fundus autofluorescence (Fig. 4E) that for the most part originates from RPE melanin (56). Interestingly, measurements of ONL thicknesses revealed thinning in the ob/ob mice relative to C57BL/6J mice at 2 and 4 months of age (Fig. 4, F–H). Whether photoreceptor cell degeneration obfuscated a tendency toward elevated bisretinoid has not been determined. And finally, in a fluorescence assay of PE, levels were not significantly different in ob/ob mice versus C57BL/6J mice at age 3 months (two-way ANOVA, Sidak’s multiple comparison test) (Fig. 3B).
Discussion
Numerous publications have reported on the effects on retina of an impaired retinoid cycle (57). By comparison, less is known regarding the effects of increased circulating vitamin A on the visual cycle. The salient finding of this study in mice is that an HFD not only leads to elevated Rbp4, retinol, and glucose in plasma, it also contributes to elevated levels of bisretinoids in retina. Here, the latter increase was measured both by fundus imaging and by quantitative HPLC/UPLC.
For transport in the circulatory system, retinol forms a holo-enzyme complex with RBP4 and TTR (45, 46). Approximately 85% of serum RBP4 is found within this complex with the remaining being apo-RBP4 (58). At target cells, RBP4-TTR binds to cell surface STRA6 (stimulated by retinoic acid 6) (59), and retinol enters the RPE cell where it binds to cellular retinol binding protein-1. It is also now evident that calcium/calmodulin regulates vitamin A transport activity by STRA6 (60). Specifically, calcium/calmodulin suppresses STRA6-mediated vitamin A uptake by promoting the binding of apo-RBP to STRA6. Binding of apo-RBP to STRA6 not only thwarts the binding of holo-RBP to STRA6, a process that is required for vitamin A uptake, binding also promotes vitamin A efflux through STRA6. Within the RPE, atRE is converted to the visual chromophore 11-cis-retinal (61). There is evidence that RBP4 also serves as a transporter of fatty acid (62).
Efficient absorption of fat-soluble vitamin A in the intestine depends on the fat-solubilizing properties of bile acids. Specifically, within the lumen of the small intestine, bile acids form mixed micelles with phospholipids that promote solubilization and absorption of dietary lipids; by incorporating vitamin A in these particles, absorption of the latter is also facilitated (63). Hence, dietary retinol absorbed by intestinal enterocytes can be converted to retinyl esters and incorporated into chylomicron particles (64, 65). The latter lipoprotein particles are composed of a central lipid core of triglycerides and as with other lipoproteins, chylomicrons carry esterified cholesterol and phospholipids. These chylomicrons serve to transport vitamin A in addition to its transport as retinol bound to RBP4. Under conditions of high fat intake, increases in liver fatty acid–binding protein L-FABP and microsomal triglyceride transfer protein, both of which are responsible for the transport of fatty acids from the cytosol to the endoplasmic reticulum and incorporation of lipid into pre-chylomicrons, may directly influence the quantity of chylomicrons reaching the circulatory system (66). When remodeling serum chylomicrons, lipoprotein lipase acts not only on lipid, it also hydrolyzes retinyl esters; the product of this lipolysis is retinol which is then taken up by extrahepatic cells (58). This alternative system of vitamin A transport may explain why in Rbp4 null mice, normal visual functioning is eventually observed (∼ age 5 months) if vitamin A intake is sufficient (65). In STRA6−/− mice, ocular retinoid concentrations are low in the young mouse but by 8 months of age reach levels that are 50% of the content in WT mice (67, 68).
The phenotype of mice deficient in leptin (ob/ob) differed from that of the HFD-fed mice. While both HFD-fed mice and ob/ob mice exhibited elevated serum Rbp4, the ob/ob mice acquired the weight gain in the absence of high fat intake and did not exhibit increased bisretinoid accumulation. This difference suggests that the HFD per se rather than the weight gain explains the bisretinoid increase. In some studies but not others, obesity in human subjects has also been associated with increased serum RBP4 (58).
The development of obesity in humans is multifactorial; it depends on genetic susceptibility, increased caloric intake, and inadequate energy expenditure. Conversely, body weight gain due to leptin deficiency (ob/ob) happens as a result of enhanced food intake even on a normal diet. Thus, the HFD-induced obesity is more representative of the human condition.
Diet-induced obesity has been reported to have other effects on retina. For instance, in C57BL/6J mice, an HFD is associated with reductions in ERG amplitudes (69, 70), and in the setting of disrupted cholesterol metabolism, an HFD accelerated rod degeneration (71). Basal laminar sub-RPE deposits form in C57BL/6J WT and APO B100 transgenic mice placed on an HFD for several months (72, 73, 74, 75). Mice deficient in apolipoprotein E4 when placed on a high fat cholesterol-enriched diet exhibit abnormal sub-RPE Aß-containing deposits (76) as do mice deficient in peroxisome proliferator-activated receptor-g coactivator 1-alpha when fed a diet high in fat (55). In mice lacking nuclear factor erythroid 2-related factor 2, an HFD caused accelerated RPE atrophy (77). One limitation of the current study was that all HFD-fed mice were male, this approach being customary (78, 79, 80).
One may have expected that the increase in bisretinoid fluorophores would reflect an increase in ocular retinoids. Nevertheless, while plasma retinol was elevated and bisretinoid formation was increased, we did not detect a change in ocular retinoids (all-trans-retinol, all-trans-retinyl ester, all-trans-retinal, 11-cis-retinal). On one hand, this finding is consistent with the work of others revealing that obesity in mice and humans is associated with unchanged tissue levels of vitamin A (47) even when the diets contain adequate amounts of retinol or retinyl palmitate (78). On the other hand, however, the magnitude of bisretinoid accumulation is known in many cases to mirror retinoid cycle kinetics (29, 31). Moreover, we have observed that a disparity in ocular retinoid, for instance due to the Rpe65-Leu450Met variant, can manifest as a more pronounced difference in bisretinoid accumulation (81) due to a cumulative effect. Thus, measurements of bisretinoid products of the visual cycle serve as an index of visual cycle activity over the long term even when changes in retinoid levels may be difficult to detect by measuring individual retinoids at any given time (82, 83).
The formation of N-retinylidene-PE by a Schiff base linkage between retinaldehyde and PE (1:1 ratio) in the photoreceptor outer segment membrane is the first step in the nonenzymatic process by which bisretinoids form. N-retinylidene-PE is also the ligand recognized by ATP-binding cassette transporter A4, a member of the ABC family of lipid transporters, that serves to deliver retinaldehyde to cytosolic retinol dehydrogenases which reduce retinaldehyde to the nonreactive retinol form (84, 85, 86, 87, 88). In previous work, we carried out a study in which we varied the ratio of all-trans-retinaldehyde to PE in synthetic mixtures to determine how these two precursors might affect the formation of A2PE, an intermediate in the A2E biosynthetic pathway. We found that the yield of A2PE increased when the ratio of equivalents of all-trans-retinal to PE was increased from 1:2 to 4:2 with no further increase being observed at a ratio of 8:2 (1). Conversely, increasing the concentration of PE from an equivalents ratio of 4:1 through 4:8 (all-trans-retinal to PE) resulted in a steady increase in A2PE synthesis. This finding indicated that the concentration of PE has a pronounced effect on the rate of A2PE synthesis. An increase in PE in the reaction mixture also favored the formation of all-trans-retinal dimer (1). These findings are consistent with a relationship between PE content and bisretinoid formation observed in association with an HFD in the current work.
In summary, we show that lipid metabolism intersects with the visual cycle and bisretinoid lipofuscin formation. We propose that dysregulation of vitamin A aldehyde in association with an HFD can lead to increased formation of bisretinoid fluorophores that constitute the lipofuscin of retina. An alternative or additional mechanism could involve HFD-associated changes in the PE content of photoreceptor cells. In addition to the current findings, it is reported that mice reared on an HFD exhibit changes in the relative proportion of omega-6 and omega-3 polyunsaturated fatty acid precursors (linoleic and alpha-linolenic acids) incorporated in the retina (89). Genes involved in lipid metabolism are also amongst 34 loci implicated in age-related macular degeneration susceptibility (90). The relationship between retinal disease and lipid metabolism is important: 70% of American adults are overweight (91) and obesity is a major contributor to disease burden. This investigation adds to existing notions regarding rates of bisretinoid formation.
Experimental procedures
Animals and treatments
Diet-induced obese mice (black C57BL/6J; Stock# 380 and albino C57BL/6Jc2j) were obtained from The Jackson Laboratory (JAX) at ages 4 to 12 months. Black male C57BL/6 mice and albino male C57BL/6Jc2j were fed an HFD with 60% of kcal from fat (4.0 IU vitamin A acetate/gm chow). Male black C57BL/6 mice also received standard diet of 10% kcal from fat (4.0 IU vitamin A acetate/gm chow), and albino C57BL/6Jc2j were fed a standard diet of 16.6% kcal from fat (20 IU vitamin A acetate/gm chow). Leptin-deficient ob/ob mice (B6.V-Lep/Job/ob) were obtained from JAX. Ob/ob mice and littermate controls were fed a diet with 13.1% kcal from fat (15 IU vitamin A acetate/gm chow). Eyes from 36-month-old DIO mice were a gift from Drs J. L. Walewski and P. D. Berk, Department Medicine, Columbia University Medical Center. C57BL/6J and C57BL/6Jc2j mice carry the methionine variant at amino acid 450 (Rpe65-Met450). WT mice, black C57BL/6J, or albino C57BL/6Jc2j mice were obtained from JAX. For consistency with published work, mice employed for studies of the effects of an HFD were male. Estrogen-associated effects on food intake and energy expenditure in female mice leads to more variable data (92). Blood glucose was measured on the day of shipment and body weight was determined immediately upon arrival.
Animal protocols were approved by the Institutional Animal Care and Use Committees of Columbia University and all procedures complied with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research. All mice had free access to water, were fed ad libitum throughout, and were maintained in a temperature-controled room at 21 to 23 °C under cyclic light (12 h: 12 h light-dark cycle).
Quantitative HPLC and UPLC of bisretinoids
Mouse eyecups were homogenized and extracted with either A or B (A: homogenized in dulbecco’s phosphate buffered saline (DPBS) and extracted with chloroform/methanol, 1:1; B: homogenized and extracted in chloroform/methanol, 1:1) using a tissue grinder. Solvent (200 μl) was added to each eyecup. To exceed the lower limit of quantification for each bisretinoid, eyes were pooled according to mouse strain (pigmentation, age, and genotypes), and samples were extracted according to procedure A or B above. Samples were extracted five times and then centrifuged at 4000g for 3 min. The extract was concentrated and redissolved in 50% methanolic chloroform. Molecular quantities of bisretinoids were presented as pmoles per eye. Bisretinoids were analyzed and quantified by reversed-phase HPLC (A2E, iso-A2E, A2-DHP-PE, atRALdi-PE) (4–10 eyes/sample as indicated) using an Alliance System (Waters Corp) and Atlantis dC18 column. Gradients of water and acetonitrile with 0.1% of TFA were used for mobile phase; 75 to 90% acetonitrile (0–30 min); 90 to 100% acetonitrile (30–40 min); 100% acetonitrile (40–80 min) with a flow rate of 0.5 ml/min. The bisretinoid A2-GPE was analyzed using a Waters Acquity UPLC-MS system and Acquity BEH phenyl column (1–4 eyes/sample as indicated) with a mobile phase of acetonitrile/water (1:1) and isopropanol/acetonitrile (9:1), both with 0.1% formic acid (UPLC condition a: 0–50 min, 100–55% acetonitrile/water in isopropanol/acetonitrile; 50–110 min, 55–35% acetonitrile/water in isopropanol/acetonitrile; flow rate of 0.2 ml/min) (23). Molar quantities per eye were calculated by comparison to synthesized standards. The pyridinium bisretinoid A2E and its cis isomer, iso-A2E were measured separately and summed (A2E).
Quantitative UPLC analysis of ocular and plasma retinoids
For extraction of ocular retinoids, frozen mouse eyecups (1 eye/sample) were homogenized and derivatized with O-ethylhydroxylamine (100 mM) in DPBS (, pH 6.5, without CaCl2 and MgCl2) (method 1) or with O-ethylhydroxylamine (100 mM) and acetonitrile (method 2) on ice under dim red light. After vortexing, samples were allowed to stand for 15 min at 4 °C. Methanol (1 ml) was added (method 1) or was not added (method 2), and the ocular retinoids were extracted with hexane (3 ml, 3 times) and then resuspended in 20 μl of acetonitrile for UPLC analysis (93). Mouse plasma samples collected using EDTA were centrifuged at 1000g for 10 min at 4 °C. For extraction of retinoids, 1 ml of methanol and 120 μl of 1M O-ethylhydroxylamine in DPBS (pH 6.5, without CaCl2 and MgCl2) were added to 200 μl of plasma (final concentration of O-ethylhydroxylamine, 100 mM). Plasma retinoids were extracted with hexane (5 ml, 2 times) and then resuspended in 10 μl of acetonitrile for UPLC analysis. For quantitative retinoids analysis, a Waters Acquity UPLC-PDA system was used with a CSH C18 column (1.7 μm, 2.1 × 100 mm) and gradients of water (A) and acetonitrile (B) with 0.1% of formic acid as described (32). Molar quantities per eye were calculated based on standard curves determined spectrophotometrically. Peak areas were calculated using Waters Empower Software (https://www.waters.com/nextgen/us/en/products/informatics-and-software/waters_connect.html), and results were analyzed in Excel (Microsoft). O-Ethylhydroxylamine was used to convert retinaldehyde into a stable oxime product for accurate quantitation.
Measurements of RBP4 protein by ELISA
Mouse plasma samples collected using EDTA were centrifuged at 1000g for 10 min at 4 °C. The plasma samples were diluted with the sample diluent buffer provided in the kit in a ratio of 1 either to 500,000 or 1,000,000 and measured using a commercial RBP4 mouse ELISA kit (Abcam) following the manufacturer’s guidelines. Absorbance was read at 450 nm, and corresponding RBP4 protein level (microG/ml) was determined by reference to a standard curve (absorbance as a function of log concentration) and the use of a four-parameter fit algorithm (94). A control blank value was subtracted from all readings.
Fundus imaging
Mice were anesthetized, pupils were dilated, the cornea was lubricated, and mice were positioned as previously described (15). Fundus AF images (55° wide field lens; 0.98-mm detection pupil) at 488 nm and 790 nm excitation were obtained with a confocal scanning laser ophthalmoscope (Spectralis HRA; Heidelberg Engineering) with laser power set at approximately 280 μW and sensitivity at 100 and 105, respectively, after visual pigment was bleached for 20 s. Nine successive frames were acquired at 488 nm excitation with the high-speed mode, and frames were saved in non-normalized mode. A mean of 100 frames was obtained at 790-nm excitation with high-resolution automatic real-time mode and resized with Photoshop CS4 (Adobe Systems, Inc) to 768 × 768 pixels, the same as high-speed mode images. Near-infrared reflectance images (820 nm) were also acquired.
Quantitative fundus autofluorescence
Using a dedicated image analysis program written in IGOR (Wavemetrics), mean gray levels (GLs) were calculated from eight predefined segments around the optic disc, and blood vessels were excluded by histogram analysis. qAF at 488-nm excitation was calculated by normalization to the GL of the reference after subtraction of zero light (GL0) and inclusion of a reference calibration factor (15). Fluorescence intensities at 790 nm were calculated by subtracting the minimal GL of optic nerve head (ONH) measured by ImageJ software (http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health).
Measurement of ONL thickness
Following sacrifice and enucleation, eyes were immersed in 4% paraformaldehyde for 24 h at 4 °C. Sagittal paraffin serial sections of mouse retina were prepared and stained with H&E. The section most centrally positioned in the ONH was selected and imaged with the 20× objective using a digital imaging system (Leica Microsystems; Leica Application suite), and composite images were created in Photoshop CS5. ONL thickness was then measured at 200 micron intervals superior and inferior to the edge of the ONH along the vertical meridian (95). The measurements were made using the Photoshop CS5 ruler tool and a custom measurement scale. ONL width in pixels was converted to microns (1 pixel: 0.23 μm). For groups of mice at defined ages, mean ONL thickness at each position along the vertical meridian was plotted as a function of eccentricity from the ONH. ONL area was calculated as the measurement interval of 0.2 mm multiplied by the sum of ONL thicknesses in superior and inferior hemiretina.
Assay of PE
Dissected ocular tissues were homogenized in a 5% (v/v) solution of peroxide free Triton X-100 in water using an ultrasonic homogenizer. The homogenate solution was heated to 80 °C for 5 to 10 min and then cooled down to room temperature. The latter process was repeated to solubilize all lipids. After centrifugation (10,000g, 10 min, 4 °C), samples were collected from supernatant. PE content was measured in the samples using a fluorescence assay kit whereby a PE converter hydrolyzes PE to an intermediate which converts a colorless probe to a fluorescent product via enzymatic reaction (Ex/Em: 535/587) (ab241005 PE assay kit, Abcam).
Statistical analysis
Statistical analysis was carried out using GraphPad Prism 8.0, and p < 0.05 was considered significant. Effect size (d) was calculated as (mean1−mean2)/pooled SD (96).
Data availability
All of the data are in the manuscript. Histological images and chromatograms are available on request.
Conflicts of interest
The authors declare that there are no conflicts of interest related to the contents of this article.
Acknowledgments
This work was supported by grants from the National Eye Institute (EY012951, S10OD028637; and P30EY019007) and Research to Prevent Blindness to the Department of Ophthalmology, Columbia University.
Author contributions
H. J. K., J. Z., and J. R. S. conceptualization; H. J. K. and J. R. S. writing–original draft; H. J. K., J. Z., and J. R. S. writing–review & editing; J. R. S. funding acquisition; H. J. K. and J. Z. investigation; J. L. W resources.
Reviewed by members of the JBC Editorial Board. Edited by Kirill Martemyanov
Footnotes
Present addresses for: Hye Jin Kim, College of Pharmacy, Keimyung University, 1095 Dalgubeol-daero, Sindang-dong, Dalseo-gu, Daegu, South Korea; Jose L. Walewski, Picaflor Therapeutics LLC.
References
- 1.Sparrow J.R., Gregory-Roberts E., Yamamoto K., Blonska A., Ghosh S.K., Ueda K., et al. The bisretinoids of retinal pigment epithelium. Prog. Retin. Eye Res. 2012;31:121–135. doi: 10.1016/j.preteyeres.2011.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ben-Shabat S., Itagaki Y., Jockusch S., Sparrow J.R., Turro N.J., Nakanishi K. Formation of a nona-oxirane from A2E, a lipofuscin fluorophore related to macular degeneration, and evidence of singlet oxygen involvement. Angew. Chem. Int. Ed. Engl. 2002;41:814–817. doi: 10.1002/1521-3773(20020301)41:5<814::aid-anie814>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- 3.Eldred G.E., Katz M.L. Fluorophores of the human retinal pigment epithelium: separation and spectral characterization. Exp. Eye Res. 1988;47:71–86. doi: 10.1016/0014-4835(88)90025-5. [DOI] [PubMed] [Google Scholar]
- 4.Katz M.L., Drea C.M., Eldred G.E., Hess H.H., Robison W.G., Jr. Influence of early photoreceptor degeneration on lipofuscin in the retinal pigment epithelium. Exp. Eye Res. 1986;43:561–573. doi: 10.1016/s0014-4835(86)80023-9. [DOI] [PubMed] [Google Scholar]
- 5.Liu J., Itagaki Y., Ben-Shabat S., Nakanishi K., Sparrow J.R. The biosynthesis of A2E, a fluorophore of aging retina, involves the formation of the precursor, A2-PE, in the photoreceptor outer segment membrane. J. Biol. Chem. 2000;275:29354–29360. doi: 10.1074/jbc.M910191199. [DOI] [PubMed] [Google Scholar]
- 6.Young R.W., Bok D. Participation of the retinal pigment epithelium in the rod outer segment renewal process. J. Cell Biol. 1969;42:392–403. doi: 10.1083/jcb.42.2.392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Parish C.A., Hashimoto M., Nakanishi K., Dillon J., Sparrow J.R. Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc. Natl. Acad. Sci. U. S. A. 1998;95:14609–14613. doi: 10.1073/pnas.95.25.14609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Weng J., Mata N.L., Azarian S.M., Tzekov R.T., Birch D.G., Travis G.H. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell. 1999;98:13–23. doi: 10.1016/S0092-8674(00)80602-9. [DOI] [PubMed] [Google Scholar]
- 9.Delori F.C. Spectrophotometer for noninvasive measurement of intrinsic fluorescence and reflectance of the ocular fundus. Appl. Opt. 1994;33:7439–7452. doi: 10.1364/AO.33.007439. [DOI] [PubMed] [Google Scholar]
- 10.von Ruckmann A., Fitzke F.W., Bird A.C. Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br. J. Ophthalmol. 1995;79:407–412. doi: 10.1136/bjo.79.5.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Delori F.A., Duncker T., Sparrow J.R. In: Fundus Autofluorescence. Lois N., Forrester J.V., editors. Wolters Kluwer; Philadelphia: 2016. The measurement of fundus autofluorescence levels; pp. 52–58. [Google Scholar]
- 12.Duncker T., Greenberg J.P., Ramachandran R., Hood D.C., Smith R.T., Hirose T., et al. Quantitative fundus autofluorescence and optical coherence tomography in best vitelliform macular dystrophy. Invest. Ophthalmol. Vis. Sci. 2014;55:1471–1482. doi: 10.1167/iovs.13-13834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Duncker T., Tsang S.H., Lee W., Zernant J., Allikmets R., Delori F.C., et al. Quantitative fundus autofluorescence distinguishes ABCA4-associated and non-ABCA4-associated Bull's-eye maculopathy. Ophthalmology. 2015;122:345–355. doi: 10.1016/j.ophtha.2014.08.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Greenberg J.P., Duncker T., Woods R.L., Smith R.T., Sparrow J.R., Delori F.C. Quantitative fundus autofluorescence in healthy eyes. Invest. Ophthalmol. Vis. Sci. 2013;54:5684–5693. doi: 10.1167/iovs.13-12445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sparrow J.R., Blonska A., Flynn E., Duncker T., Greenberg J.P., Secondi R., et al. Quantitative fundus autofluorescence in mice: correlation with HPLC quantitation of RPE lipofuscin and measurement of retina outer nuclear layer thickness. Invest. Ophthalmol. Vis. Sci. 2013;54:2812–2820. doi: 10.1167/iovs.12-11490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sparrow J.R., Duncker T., Schuerch K., Paavo M., de Carvalho J.R.L., Jr. Lessons learned from quantitative fundus autofluorescence. Prog. Retin. Eye Res. 2020;74 doi: 10.1016/j.preteyeres.2019.100774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wu Y., Yanase E., Feng X., Siegel M.M., Sparrow J.R. Structural characterization of bisretinoid A2E photocleavage products and implications for age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2010;107:7275–7280. doi: 10.1073/pnas.0913112107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yoon K.D., Yamamoto K., Ueda K., Zhou J., Sparrow J.R. A novel source of methylglyoxal and glyoxal in retina: implications for age-related macular degeneration. PLoS One. 2012;7 doi: 10.1371/journal.pone.0041309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Feeney-Burns L., Hilderbrand E.S., Eldridge S. Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. Invest. Ophthalmol. Vis. Sci. 1984;25:195–200. [PubMed] [Google Scholar]
- 20.Kim S.R., Jang Y.P., Jockusch S., Fishkin N.E., Turro N.J., Sparrow J.R. The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model. Proc. Natl. Acad. Sci. U. S. A. 2007;104:19273–19278. doi: 10.1073/pnas.0708714104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Weiter J.J., Delori F.C., Wing G.L., Fitch K.A. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest. Ophthalmol. Vis. Sci. 1986;27:145–151. [PubMed] [Google Scholar]
- 22.Wing G.L., Blanchard G.C., Weiter J.J. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 1978;17:601–607. [PubMed] [Google Scholar]
- 23.Ueda K., Zhao J., Kim H.J., Sparrow J.R. Photodegradation of retinal bisretinoids in mouse models and implications for macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2016;113:6904–6909. doi: 10.1073/pnas.1524774113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Dobri N., Qin Q., Kong J., Yamamoto K., Liu Z., Moiseyev G., et al. A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis. Invest. Ophthalmol. Vis. Sci. 2013;54:85–95. doi: 10.1167/iovs.12-10050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Radu R.A., Han Y., Bui T.V., Nusinowitz S., Bok D., Lichter J., et al. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest. Ophthalmol. Vis. Sci. 2005;46:4393–4401. doi: 10.1167/iovs.05-0820. [DOI] [PubMed] [Google Scholar]
- 26.Kim S.R., Fishkin N., Kong J., Nakanishi K., Allikmets R., Sparrow J.R. The Rpe65 Leu450Met variant is associated with reduced levels of the RPE lipofuscin fluorophores A2E and iso-A2E. Proc. Natl. Acad. Sci. U. S. A. 2004;101:11668–11672. doi: 10.1073/pnas.0403499101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Katz M.L., Redmond T.M. Effect of Rpe65 knockout on accumulation of lipofuscin fluorophores in the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2001;42:3023–3030. [PubMed] [Google Scholar]
- 28.Wu L., Ueda K., Nagasaki T., Sparrow J.R. Light damage in Abca4 and Rpe65rd12 mice. Invest. Ophthalmol. Vis. Sci. 2014;55:1910–1918. doi: 10.1167/iovs.14-13867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Golczak M., Kuksa V., Maeda T., Moise A.R., Palczewski K. Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle. Proc. Natl. Acad. Sci. U. S. A. 2005;102:8162–8167. doi: 10.1073/pnas.0503318102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Kiser P.D., Zhang J., Badiee M., Li Q., Shi W., Sui X., et al. Catalytic mechanism of a retinoid isomerase essential for vertebrate vision. Nat. Chem. Biol. 2015;11:409–415. doi: 10.1038/nchembio.1799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Maiti P., Kong J., Kim S.R., Sparrow J.R., Allikmets R., Rando R.R. Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation. Biochemistry. 2006;45:852–860. doi: 10.1021/bi0518545. [DOI] [PubMed] [Google Scholar]
- 32.Lima de Carvalho J.R., Jr., Kim H.J., Ueda K., Zhao J., Owji A.P., Yang T., et al. Effects of deficiency in the RLBP1-encoded visual cycle protein CRALBP on visual dysfunction in humans and mice. J. Biol. Chem. 2020;295:6767–6780. doi: 10.1074/jbc.RA120.012695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Oh J.K., Lima de Carvalho J.R., Jr., Ryu J., Tsang S.H., Sparrow J.R. Short-wavelength and near-infrared autofluorescence in patients with deficiencies of the visual cycle and Phototransduction. Sci. Rep. 2020;10:8998. doi: 10.1038/s41598-020-65763-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Burke T.R., Duncker T., Woods R.L., Greenberg J.P., Zernant J., Tsang S.H., et al. Quantitative fundus autofluorescence in recessive stargardt disease. Invest. Ophthalmol. Vis. Sci. 2014;55:2841–2852. doi: 10.1167/iovs.13-13624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Chrispell J.D., Feathers K.L., Kane M.A., Kim C.Y., Brooks M., Khanna R., et al. Rdh12 activity and effects on retinoid processing in the murine retina. J. Biol. Chem. 2009;284:21468–21477. doi: 10.1074/jbc.M109.020966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Delori F.C., Staurenghi G., Arend O., Dorey C.K., Goger D.G., Weiter J.J. In vivo measurement of lipofuscin in Stargardt's disease--Fundus flavimaculatus. Invest. Ophthalmol. Vis. Sci. 1995;36:2327–2331. [PubMed] [Google Scholar]
- 37.Maeda A., Maeda T., Golczak M., Palczewski K. Retinopathy in mice induced by disrupted all-trans-retinal clearance. J. Biol. Chem. 2008;283:26684–26693. doi: 10.1074/jbc.M804505200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Radu R.A., Yuan Q., Hu J., Peng J.H., Lloyd M., Nusinowitz S., et al. Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following vitamin A supplementation. Invest. Ophthalmol. Vis. Sci. 2008;49:3821–3829. doi: 10.1167/iovs.07-1470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Cui X., Kim H.J., Cheng C.H., Jenny L.A., Lima de Carvalho J.R., Chang Y.J., et al. Long-term vitamin A supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa. Hum. Mol. Genet. 2022;31:2438–2451. doi: 10.1093/hmg/ddac032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Lee S.A., Yuen J.J., Jiang H., Kahn B.B., Blaner W.S. Adipocyte-specific overexpression of retinol-binding protein 4 causes hepatic steatosis in mice. Hepatology. 2016;64:1534–1546. doi: 10.1002/hep.28659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Skowronski A.A., Ravussin Y., Leibel R.L., LeDuc C.A. Energy homeostasis in leptin deficient Lepob/ob mice. PLoS One. 2017;12 doi: 10.1371/journal.pone.0189784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Wu Y., Fishkin N.E., Pande A., Pande J., Sparrow J.R. Novel lipofuscin bisretinoids prominent in human retina and in a model of recessive Stargardt disease. J. Biol. Chem. 2009;284:20155–20166. doi: 10.1074/jbc.M109.021345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Yamamoto K., Yoon K.D., Ueda K., Hashimoto M., Sparrow J.R. A novel bisretinoid of retina is an adduct on glycerophosphoethanolamine. Invest. Ophthalmol. Vis. Sci. 2011;52:9084–9090. doi: 10.1167/iovs.11-8632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Ferdous S., Liao K.L., Gefke I.D., Summers V.R., Wu W., Donaldson K.J., et al. Age-related retinal changes in wild-type C57BL/6J mice between 2 and 32 months. Invest. Ophthalmol. Vis. Sci. 2021;62:9. doi: 10.1167/iovs.62.7.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Berry D.C., Jacobs H., Marwarha G., Gely-Pernot A., O'Byrne S.M., DeSantis D., et al. The STRA6 receptor is essential for retinol-binding protein-induced insulin resistance but not for maintaining vitamin A homeostasis in tissues other than the eye. J. Biol. Chem. 2013;288:24528–24539. doi: 10.1074/jbc.M113.484014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Noy N. Retinoid-binding proteins: mediators of retinoid action. Biochem. J. 2000;348:481–495. [PMC free article] [PubMed] [Google Scholar]
- 47.Melis M., Tang X.H., Trasino S.E., Patel V.M., Stummer D.J., Jessurun J., et al. Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease. PLoS One. 2019;14 doi: 10.1371/journal.pone.0211071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Jeon C.J., Strettoi E., Masland R.H. The major cell populations of the mouse retina. J. Neurosci. 1998;18:8936–8946. doi: 10.1523/JNEUROSCI.18-21-08936.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Morrow E.M., Furukawa T., Cepko C.L. Vertebrate photoreceptor cell development and disease. Trends Cell Biol. 1998;8:353–358. doi: 10.1016/s0962-8924(98)01341-5. [DOI] [PubMed] [Google Scholar]
- 50.Swaroop A., Kim D., Forrest D. Transcriptional regulation of photoreceptor development and homeostasis in the mammalian retina. Nat. Rev. Neurosci. 2010;11:563–576. doi: 10.1038/nrn2880. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Fliesler S.J., Anderson R.E. Chemistry and metabolism of lipids inthe vertebrate retina. Prog. Lipid Res. 1983;22:79–131. doi: 10.1016/0163-7827(83)90004-8. [DOI] [PubMed] [Google Scholar]
- 52.Mody N., Graham T.E., Tsuji Y., Yang Q., Kahn B.B. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. Am. J. Physiol. Endocrinol. Metab. 2008;294:E785–E793. doi: 10.1152/ajpendo.00521.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Manolescu D.C., Sima A., Bhat P.V. All-trans retinoic acid lowers serum retinol-binding protein 4 concentrations and increases insulin sensitivity in diabetic mice. J. Nutr. 2010;140:311–316. doi: 10.3945/jn.109.115147. [DOI] [PubMed] [Google Scholar]
- 54.Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436:356–362. doi: 10.1038/nature03711. [DOI] [PubMed] [Google Scholar]
- 55.Zhao J., Ueda K., Riera M., Kim H.J., Sparrow J.R. Bisretinoids mediate light sensitivity resulting in photoreceptor cell degeneration in mice lacking the receptor tyrosine kinase Mer. J. Biol. Chem. 2018;293:19400–19410. doi: 10.1074/jbc.RA118.005949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Keilhauer C.N., Delori F.C. Near-infrared autofluorescence imaging of the fundus: visualization of ocular melanin. Invest. Ophthalmol. Vis. Sci. 2006;47:3556–3564. doi: 10.1167/iovs.06-0122. [DOI] [PubMed] [Google Scholar]
- 57.Kiser P.D., Golczak M., Maeda A., Palczewski K. Key enzymes of the retinoid (visual) cycle in vertebrate retina. Biochim. Biophys. Acta. 2012;1821:137–151. doi: 10.1016/j.bbalip.2011.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Blaner W.S. Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders. Pharmacol. Ther. 2019;197:153–178. doi: 10.1016/j.pharmthera.2019.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Kawaguchi R., Yu J., Honda J., Hu J., Whitelegge J., Ping P., et al. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science. 2007;315:820–825. doi: 10.1126/science.1136244. [DOI] [PubMed] [Google Scholar]
- 60.Zhong M., Kawaguchi R., Costabile B., Tang Y., Hu J., Cheng G., et al. Regulatory mechanism for the transmembrane receptor that mediates bidirectional vitamin A transport. Proc. Natl. Acad. Sci. U. S. A. 2020;117:9857–9864. doi: 10.1073/pnas.1918540117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.von Lintig J., Kiser P.D., Golczak M., Palczewski K. The biochemical and structural basis for trans-to-cis isomerization of retinoids in the chemistry of vision. Trends Biochem. Sci. 2010;35:400–410. doi: 10.1016/j.tibs.2010.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Perduca M., Nicolis S., Mannucci B., Galliano M., Monaco H.L. Human plasma retinol-binding protein (RBP4) is also a fatty acid-binding protein. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 2018;1863:458–466. doi: 10.1016/j.bbalip.2018.01.010. [DOI] [PubMed] [Google Scholar]
- 63.Saeed A., Yang J., Heegsma J., Groen A.K., van Mil S.W.C., Paulusma C.C., et al. Farnesoid X receptor and bile acids regulate vitamin A storage. Sci. Rep. 2019;9 doi: 10.1038/s41598-019-55988-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.D'Ambrosio D.N., Clugston R.D., Blaner W.S. Vitamin A metabolism: an update. Nutrients. 2011;3:63–103. doi: 10.3390/nu3010063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Quadro L., Hamberger L., Colantuoni V., Gottesman M.E., Blaner W.S. Understanding the physiological role of retinol-binding protein in vitamin A metabolism using transgenic and knock out mouse models. Mol. Aspects Med. 2003;24:421–430. doi: 10.1016/s0098-2997(03)00038-4. [DOI] [PubMed] [Google Scholar]
- 66.Hijo A.H.T., Coutinho C.P., Alba-Loureiro T.C., Leite J.S.M., Bargi-Souza P., Goulart-Silva F. High fat diet modulates the protein content of nutrient transporters in the small intestine of mice: possible involvement of PKA and PKC activity. Heliyon. 2019;5 doi: 10.1016/j.heliyon.2019.e02611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Ramkumar S., Parmar V.M., Samuels I., Berger N.A., Jastrzebska B., Von Lintig J. The vitamin A transporter STRA6 adjusts the stoichiometry of chromophore and opsins in visual pigment synthesis and recycling human. Mol. Genet. 2022;31:548–560. doi: 10.1093/hmg/ddab267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Ruiz A., Mark M., Jacobs H., Klopfenstein M., Hu J., Lloyd M., et al. Retinoid content, visual responses, and ocular morphology are compromised in the retinas of mice lacking the retinol-binding protein receptor, STRA6. Invest. Ophthalmol. Vis. Sci. 2012;53:3027–3039. doi: 10.1167/iovs.11-8476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Chang R.C., Shi L., Huang C.C., Kim A.J., Ko M.L., Zhou B., et al. High-fat diet-induced retinal dysfunction. Invest. Ophthalmol. Vis. Sci. 2015;56:2367–2380. doi: 10.1167/iovs.14-16143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Kim A.J., Chang J.Y., Shi L., Chang R.C., Ko M.L., Ko G.Y. The effects of metformin on obesity-induced dysfunctional retinas. Invest. Ophthalmol. Vis. Sci. 2017;58:106–118. doi: 10.1167/iovs.16-20691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Ban N., Lee T.J., Sene A., Dong Z., Santeford A., Lin J.B., et al. Disrupted cholesterol metabolism promotes age-related photoreceptor neurodegeneration. J. Lipid Res. 2018;59:1414–1423. doi: 10.1194/jlr.M084442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Cousins S.W., Espinosa-Heidmann D.G., Alexandridou A., Sall J., Dubovy S., Csaky K. The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation. Exp. Eye Res. 2002;75:543–553. doi: 10.1006/exer.2002.2047. [DOI] [PubMed] [Google Scholar]
- 73.Espinosa-Heidmann D.G., Sall J., Hernandez E.P., Cousins S.W. Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E. Invest. Ophthalmol. Vis. Sci. 2004;45:260–266. doi: 10.1167/iovs.03-0910. [DOI] [PubMed] [Google Scholar]
- 74.Toomey C.B., Kelly U., Saban D.R., Bowes Rickman C. Regulation of age-related macular degeneration-like pathology by complement factor H. Proc. Natl. Acad. Sci. U. S. A. 2015;112:E3040–3049. doi: 10.1073/pnas.1424391112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Dithmar S., Sharara N.A., Curcio C.A., Le N.A., Zhang Y., Brown S., et al. Murine high-fat diet and laser photochemical model of basal deposits in bruch membrane. Arch. Ophthalmol. 2001;119:1643–1649. doi: 10.1001/archopht.119.11.1643. [DOI] [PubMed] [Google Scholar]
- 76.Ding J.D., Johnson L.V., Herrmann R.K., Farsiu S., Smith S.G., Groelle M., et al. Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2011;108:E279–287. doi: 10.1073/pnas.1100901108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Zhao Z., Xu P., Jie Z., Zuo Y., Yu B., Soong L., et al. Gammadelta T cells as a major source of IL-17 production during age-dependent RPE degeneration. Invest. Ophthalmol. Vis. Sci. 2014;55:6580–6589. doi: 10.1167/iovs.14-15166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Trasino S.E., Tang X.H., Jessurun J., Gudas L.J. Obesity leads to tissue, but not serum vitamin A deficiency. Sci. Rep. 2015;5 doi: 10.1038/srep15893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Wang J., Ortiz C., Fontenot L., Mukhopadhyay R., Xie Y., Law I.K.M., et al. Elafin inhibits obesity, hyperglycemia, and liver steatosis in high-fat diet-treated male mice. Sci. Rep. 2020;10 doi: 10.1038/s41598-020-69634-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Zemany L., Bhanot S., Peroni O.D., Murray S.F., Moraes-Vieira P.M., Castoldi A., et al. Transthyretin antisense oligonucleotides lower circulating RBP4 levels and improve insulin sensitivity in obese mice. Diabetes. 2015;64:1603–1614. doi: 10.2337/db14-0970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Kim H.J., Zhao J., Sparrow J.R. Vitamin A aldehyde-taurine adduct and the visual cycle. Proc. Natl. Acad. Sci. U. S. A. 2020;117:24867–24875. doi: 10.1073/pnas.2005714117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Kolesnikova M., Lima de Carvalho J.R., Jr., Parmann R., Kim A.H., Mahajan V.B., Tsang S.H., et al. Chorioretinal atrophy following voretigene neparvovec despite the presence of fundus autofluorescence. Mol. Genet. Genomic Med. 2022;10 doi: 10.1002/mgg3.2038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Lima de Carvalho J.R., Jr., Tsang S.H., Sparrow J.R. Vitamin a deficiency monitored by quantitative short wavelength fundus autofluorescence in a case of bariatric surgery. Retin. Cases Brief Rep. 2022;16:218–221. doi: 10.1097/ICB.0000000000000931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Beharry S., Zhong M., Molday R.S. N-retinylidene-phosphatidylethanolamine is the preferred retinoid substrate for the photoreceptor-specific ABC transporter ABCA4 (ABCR) J. Biol. Chem. 2004;279:53972–53979. doi: 10.1074/jbc.M405216200. [DOI] [PubMed] [Google Scholar]
- 85.Molday L.L., Rabin A.R., Molday R.S. ABCR expression in foveal cone photoreceptors and its role in Stargardt macular dystrophy. Nat. Genet. 2000;25:257–258. doi: 10.1038/77004. [DOI] [PubMed] [Google Scholar]
- 86.Molday R.S., Molday L.L. Identification and characterization of multiple forms of rhodopsin and minor proteins in frog and bovine outer segment disc membranes. Electrophoresis, lectin labeling and proteolysis studies. J. Biol. Chem. 1979;254:4653–4660. [PubMed] [Google Scholar]
- 87.Papermaster D.S., Schneider B.G., Zorn M.A., Kraehenbuhl J.P. Immunocytochemical localization of a large intrinsic membrane protein to the incisures and margins of frog rod outer segment disks. J. Cell Biol. 1978;78:415–425. doi: 10.1083/jcb.78.2.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Sun H., Nathans J. Stargardt's ABCR is localized to the disc membrane of retinal rod outer segments. Nat. Genet. 1997;17:15–16. doi: 10.1038/ng0997-15. [DOI] [PubMed] [Google Scholar]
- 89.Albouery M., Buteau B., Gregoire S., Martine L., Gambert S., Bron A.M., et al. Impact of a high-fat diet on the fatty acid composition of the retina. Exp. Eye Res. 2020;196 doi: 10.1016/j.exer.2020.108059. [DOI] [PubMed] [Google Scholar]
- 90.Fritsche L.G., Igl W., Bailey J.N., Grassmann F., Sengupta S., Bragg-Gresham J.L., et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat. Genet. 2016;48:134–143. doi: 10.1038/ng.3448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Ludwig D., Rogoff K. New York Times; New York City , NY: 2018. The Toll of America’s Obesity. [Google Scholar]
- 92.Huang K.P., Ronveaux C.C., Knotts T.A., Rutkowsky J.R., Ramsey J.J., Raybould H.E. Sex differences in response to short-term high fat diet in mice. Physiol. Behav. 2020;221 doi: 10.1016/j.physbeh.2020.112894. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Kane M.A., Folias A.E., Napoli J.L. HPLC/UV quantitation of retinal, retinol, and retinyl esters in serum and tissues. Anal. Biochem. 2008;378:71–79. doi: 10.1016/j.ab.2008.03.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Canellas P.F., Karu A.E. Statistical package for analysis of competition ELISA results. J. Immunol. Methods. 1981;47:375–385. doi: 10.1016/0022-1759(81)90294-5. [DOI] [PubMed] [Google Scholar]
- 95.Wu L., Nagasaki T., Sparrow J.R. Photoreceptor cell degeneration in Abcr-/- mice. Adv. Exp. Med. Biol. 2010;664:533–539. doi: 10.1007/978-1-4419-1399-9_61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Cohen J. 2nd Ed. L. Erlbaum Associates; Hillsdale, NJ: 1988. Statistical Power Analysis for the Behavioral Sciences. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All of the data are in the manuscript. Histological images and chromatograms are available on request.